title: Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.
authors.affiliation: Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Coriat
authors.affiliation: Saint Antoine, France.
authors.forename: B
authors.initials: B
authors.lastname: Guidet
authors.affiliation: Ghent, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: de Hert
authors.affiliation: Munich, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Kochs
authors.affiliation: Vienna, Austria.
authors.forename: S
authors.initials: S
authors.lastname: Kozek
authors.affiliation: Muenster, Germany hva@uni-muenster.de.
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
mesh_terms: D005440:Fluid Therapy / Q000592:standards*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000592:standards*; D010952:Plasma Substitutes / Q000592:standards*; D012151:Resuscitation / Q000592:standards*
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes